Baker Biotech Capital (GP), LLC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Baker Biotech Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Biotech Capital (GP), LLC. Baker Biotech Capital (GP), LLC is a 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and a Director in SEATTLE GENETICS INC /WA ($SGEN) and a Director in GENOMIC HEALTH INC ($GHDX).
Address: 667 MADISON AVE 17TH FLOOR NEW YORK 10021 NY
Companies in which Baker Biotech Capital (GP), LLC is an Insider
Ardea Biosciences, Inc./DE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Biotech Capital (GP), LLC: 10% Owner
Holdings: 478,376 shares
Latest Transaction: Feb 28 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GENOMIC HEALTH INC
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of Baker Biotech Capital (GP), LLC: Director
Holdings: 233,732 shares
Current Value: $6,425,293
Latest Transaction: Sep 11 2006
$GHDX Market Capitalization: $928.37M
$GHDX Previous Close: $27.49
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Seagen Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Biotech Capital (GP), LLC: Director
Holdings: 1,535,999 shares
Current Value: $93,373,379
Latest Transaction: Aug 16 2006
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Baker Biotech Capital (GP), LLC
Sentiment: All, IBPI, GHDX, SGEN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 16 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.05 | 12,080 | 48,924 | 1,535,999 | 1.5 M to 1.5 M (+0.79 %) |
| Aug 10 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.05 | 11,838 | 47,943 | 1,480,319 | 1.5 M to 1.5 M (+0.81 %) |
| Aug 10 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.05 | 51,819 | 209,867 | 1,468,481 | 1.4 M to 1.5 M (+3.66 %) |
| Aug 10 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.05 | 2,416 | 9,779 | 1,416,662 | 1.4 M to 1.4 M (+0.17 %) |
| Aug 15 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.03 | 34,745 | 139,991 | 1,523,919 | 1.5 M to 1.5 M (+2.33 %) |
| Aug 15 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.03 | 834 | 3,361 | 1,489,174 | 1.5 M to 1.5 M (+0.06 %) |
| Aug 15 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.04 | 338 | 1,364 | 1,488,340 | 1.5 M to 1.5 M (+0.02 %) |
View all Baker Biotech Capital (GP), LLC insider transactions.